The FDA usually protects corporate information, such as what manufacturing unit a drug is designed in, for concern of working afoul of trade magic formula guidelines. In 2011, the FDA reported it observed 1,900 instances in the course of an inspection of the Cetero Investigate facility in which lab specialists that supposedly conducted certain test